COVID Vaccines: Yes, There Is Some Risk — But COVID Infection Causes Far More Harm
People living with aspergillosis, CPA, ABPA, bronchiectasis, asthma or sarcoidosis often feel understandably anxious about vaccination.
Concerns about myocarditis, side effects, and frightening stories online are completely normal.
But when you compare the risks of the vaccine with the risks of COVID infection, a clear picture emerges:
⚠️ The vaccine carries some risk
🚨 COVID infection carries far, far more risk — and affects almost everyone
This article explains that difference clearly and honestly.
1. COVID vaccines can cause harm — but this is rare
No medical treatment is risk-free.
A very small number of people experience:
-
Fever
-
Fatigue
-
Headache
-
Swollen glands
-
Sore arm
-
Mild myocarditis (usually short-lived, rare, and mostly in young men)
Serious reactions such as hospitalisation or anaphylaxis are extremely rare — roughly 1–2 cases per million doses.
We should acknowledge this openly.
2. Almost everyone has had COVID in the last five years
Across the UK and most of the world, over 90% of adults now show antibodies from a past COVID infection, even if they didn’t realise they had it.
Many infections felt like a cold or passed unnoticed, but the body still experienced real risks:
-
heart inflammation
-
blood clots
-
lung inflammation
-
long-term fatigue
-
worsening of existing lung disease
Many people have had COVID more than once, and the risks increase with repeated infections.
So when we compare vaccine risk with infection risk, we’re not discussing a rare scenario — we are talking about something nearly everyone has already experienced, often multiple times.
3. COVID vaccines have prevented millions of hospitalisations and deaths
Global studies estimate that:
-
In the first year alone, COVID vaccines prevented around 19 million deaths worldwide.
-
WHO Europe reports more than 1.4 million lives saved in Europe alone.
-
A wider analysis suggests vaccines prevented over half of all potential hospitalisations and severe outcomes across many countries.
A simple way to think about it:
For every serious vaccine reaction, the vaccine prevents tens of thousands of hospitalisations and deaths.
This benefit is especially important for people with:
-
chronic lung disease
-
aspergillosis
-
bronchiectasis
-
asthma
-
immune suppression
-
long-term steroid use
For these groups, the protective effect of vaccination is greater than average, because COVID complications are more dangerous.
4. COVID infection causes far more harm than the vaccine
This is the crucial point.
COVID infection is 30–100 times more likely to cause myocarditis than the vaccine.
And infection-related myocarditis is:
-
more severe
-
more likely to require hospital care
-
more likely to leave long-term effects
COVID infection also increases the risk of:
-
blood clots
-
heart attacks
-
strokes
-
lung scarring
-
long COVID
-
ICU admission
-
worsening of asthma, ABPA, CPA and bronchiectasis
And the risk of death from infection is hundreds of times higher than the risk from vaccination.
5. Why scare stories feel louder than scientific facts
Scary individual stories spread quickly online.
But they are rare.
What we don’t see in the same dramatic way:
-
“Thousands of vulnerable patients avoided severe illness because they were vaccinated.”
-
“Vaccination prevented hospital admissions this week.”
-
“Most myocarditis cases after vaccination recover fully within days.”
Positive outcomes never go viral — but they happen constantly.
6. What this means for people with aspergillosis
COVID infection can:
-
trigger ABPA flares
-
worsen CPA cavities
-
increase mucus blockage
-
increase breathlessness
-
raise the risk of secondary fungal infections
-
accelerate lung damage
-
lead to hospitalisation
Vaccination significantly reduces all of these risks.
For most people with aspergillosis, vaccination is far safer than repeated COVID infections.
7. A supportive message for anyone still unsure
“It's true the vaccine carries some risk — all medicines do.
But COVID infection carries far, far more risk, and nearly everyone has had it at least once already.
Vaccination is the option that best protects your heart, your lungs, and your long-term health.”
Autumn 2025 COVID-19 Booster – What Aspergillosis Patients Need to Know
The UK Health Security Agency (UKHSA) has updated who will be offered the COVID-19 booster this autumn. The programme is now more limited than in 2024, so it’s important to know if you qualify.
Who will be offered the booster?
You can get a free COVID-19 booster this autumn if you are:
-
Aged 75 or over
-
Living in a care home for older adults
-
Aged 6 months or older and immunosuppressed
This is a change from 2024, when everyone aged 65+ and many other clinical risk groups were included.
What “immunosuppressed” means
Many people with aspergillosis fall into this category. You may be considered immunosuppressed if you are:
-
Taking systemic steroids for more than a month
-
Receiving biologic therapy or other immunomodulatory medication
-
Living with a condition that affects your immune system
-
Having had chemotherapy, radiotherapy, or a transplant
If you’re unsure whether this applies to you, check with your GP or hospital specialist.
Timing of the booster
-
Boosters are usually offered at least 6 months after your last dose, including the spring booster.
-
Even if you’ve never had a COVID-19 vaccine before, you can still get one this autumn if you are in one of the eligible groups.
Why this matters for aspergillosis patients
People with aspergillosis often have weaker lungs and higher risks from infections. If your immune system is also suppressed by medication or illness, COVID-19 can be more severe. The booster offers added protection during the winter months.
💙 Key advice:
-
If you are immunosuppressed or over 75, you should be offered the vaccine.
-
If you think you qualify but haven’t received an invitation, speak to your GP or specialist.
-
Don’t delay — protecting yourself against COVID-19 is especially important when living with aspergillosis.
📌 Full details from UKHSA: Who’s eligible for the 2025 COVID-19 vaccine or autumn booster
COVID-19 News
[et_pb_section fb_built="1" _builder_version="4.16" custom_padding="0px||0px||true|false" global_colors_info="{}" theme_builder_area="post_content"][et_pb_row _builder_version="4.16" background_size="initial" background_position="top_left" background_repeat="repeat" global_colors_info="{}" theme_builder_area="post_content"][et_pb_column type="4_4" _builder_version="4.16" custom_padding="|||" global_colors_info="{}" custom_padding__hover="|||" theme_builder_area="post_content"][et_pb_text _builder_version="4.21.0" background_size="initial" background_position="top_left" background_repeat="repeat" hover_enabled="0" global_colors_info="{}" theme_builder_area="post_content" sticky_enabled="0"]
COVID-19 App no longer in use
The NHS COVID-19 app, which alerted close contacts of a positive case and provides the latest health advice about the virus, closed on 27 April 2023.
Over the past year, the success of the vaccination programme, increased access to treatments and high immunity in the population has enabled the government to target its COVID-19 services, meaning the app is no longer needed. The knowledge, technology and lessons learnt from the app will be used to help inform planning and response to future pandemic threats.
It is important that people continue to follow the latest guidance to protect themselves and others:
This includes reporting NHS lateral flow test results on GOV.UK. Those eligible for COVID-19 treatment must report their result so the NHS can contact them about treatment.
COVID-19 vaccination spring programme
The 2023 spring coronavirus (COVID-19) booster programme is now underway. A spring booster dose is being offered to:
- adults aged 75 years and over
- residents in a care home for older adults
- individuals aged 5 years and over who are immunosuppressed
Those eligible can book their vaccination on the National Booking Service or NHS App.
The last date for the public to book spring boosters will be 30 June 2023.
The offer of a first and second dose of the COVID-19 vaccine will also come to an end for many people on 30 June. After this date, the NHS offer will become more targeted to those at increased risk, usually during seasonal campaigns.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
COVID Vaccination Side Effects
[et_pb_section fb_built="1" admin_label="section" _builder_version="4.16" global_colors_info="{}" theme_builder_area="post_content" custom_padding="7px||7px||true|false"][et_pb_row admin_label="row" _builder_version="4.16" background_size="initial" background_position="top_left" background_repeat="repeat" global_colors_info="{}" theme_builder_area="post_content"][et_pb_column type="4_4" _builder_version="4.16" custom_padding="|||" global_colors_info="{}" custom_padding__hover="|||" theme_builder_area="post_content"][et_pb_text admin_label="Text" _builder_version="4.16" background_size="initial" background_position="top_left" background_repeat="repeat" global_colors_info="{}" theme_builder_area="post_content"]Now that the rollout of the second COVID vaccination (using the Pfizer/BioNTech and Oxford/AstraZeneca vaccines) are well underway in the UK attention in our aspergillosis patient communities has turned to the potential for side effects caused by these medications.
Most people suffer few or no side effects from either vaccine other than having a slightly sore arm for a day or two or feeling a few aches. Doctors are recommending that we take paracetamol to relieve those symptoms.
The UK government has now published more detailed information on side effects and all three vaccinations currently in use in the UK (a third vaccine named Moderna has recently started to be used). You can read this information at the links below:
You can also report any suspected side effect.
Full details of the UK COVID-19 vaccine program are given here.[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]


